Publications by authors named "Jennifer Smrtka"

Claim this Profile
I
Impact of Shared Decision Making on Disease-Modifying Drug Adherence in Multiple Sclerosis.
Aliza Ben-Zacharia, Meagan Adamson, Allison Boyd, Paula Hardeman, Jennifer Smrtka

Int J MS Care· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of mobility and the patient burden of multiple sclerosis: expert opinion on relevance to daily clinical practice.
Jennifer Smrtka, Theodore Brown, Greg Bjorklund

Postgrad Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis in US minority populations: Clinical practice insights.
Omar Khan, Mitzi J Williams, Lilyana Amezcua, Adil Javed, Kristin E Larsen, Jennifer M Smrtka

Neurol Clin Pract· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving role of the multiple sclerosis nurse: an international perspective.
Therese Burke, Sara Dishon, Lynn McEwan, Jennifer Smrtka

Int J MS Care· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.
Amy Perrin Ross, Alona Williamson, Jennifer Smrtka, Tracy Flemming Tracy, Carol Saunders

Mult Scler Int· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.
Amy Perrin Ross, Aliza Ben-Zacharia, Colleen Harris, Jennifer Smrtka

Front Neurol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving quality of life in multiple sclerosis: an unmet need.
Howard L Zwibel, Jennifer Smrtka

Am J Manag Care· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: adherence to disease-modifying therapies--key to optimizing outcomes in relapsing multiple sclerosis.
Christina Caon, Carol Saunders, Jennifer Smrtka, Karolyn Davis, Alan Davis

J Neurosci Nurs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data.
Christina Caon, Carol Saunders, Jennifer Smrtka, Nancy Baxter, Jennifer Shoemaker

J Neurosci Nurs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis.
Carol Saunders, Christina Caon, Jennifer Smrtka, Jennifer Shoemaker

J Neurosci Nurs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing adherence through education.
Jennifer Smrtka, Christina Caon, Carol Saunders, Brenda L Becker, Nancy Baxter

J Neurosci Nurs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
Xueyan Peng, Jianping Jin, Shailendra Giri, Monica Montes, Danuta Sujkowski, Jennifer Smrtka

J Neuroimmunol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis